For the best experience of the website, please view this site in either Microsoft Edge, Google Chrome, Safari internet browsers rather than Internet Explorer.
ATIC and The Royal Melbourne Hospital are now seeking people aged 8-45 years with recently diagnosed type 1 diabetes (within three months) for a new clinical trial of two disease-modifying medications rituximab-pvvr and abatacept, called T1D RELAY.
Collaborative focused on immunotherapy in type 1 diabetes – ANZ...
Nullam ullamcorper viverra ante sed porttitor. Curabitur erat nulla, pulvinar non leo rutrum, sagittis eleifend magna. Quisque ultricies lacinia vehicula.